Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0002-9394(80)90246-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Novel electroretinography devices to detect hydroxychloroquine retinopathy: study protocol for a diagnostic accuracy and feasibility study.
BMJ Open Ophthalmol
December 2024
Faculty of Life Sciences and Medicine, King's College London, London, UK.
Introduction: Annual screening for hydroxychloroquine (HCQ) retinopathy is recommended, and electroretinography (ERG) is considered a gold-standard test, but there are screening shortfalls and standard ERG is burdensome and has limited availability. Newer, portable ERG devices using skin-based electrodes may increase screening capacity but need validation. This study aims to determine initial device accuracies and feasibility of further research.
View Article and Find Full Text PDFAcupuncture Combined with Periocular Injection for Treatment of Hydroxychloroquine Retinopathy with Cystoid Macular Edema: A Case Report.
Chin J Integr Med
January 2025
Department of Ophthalmology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China.
For HCQ retinopathy with CME, acupuncture combined with periocular injection can be used to improve the CME and protect the central vision. Subsequent research endeavors involving a more extensive cohort and extended observation periods are warranted to evaluate the effectiveness and safety profile of the intervention.
View Article and Find Full Text PDFMimickers of hydroxychloroquine retinal toxicity.
Clin Exp Ophthalmol
December 2024
UPMC Vision Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Article Synopsis
- Hydroxychloroquine (HCQ) can cause retinal toxicity, prominently manifesting as bull's eye maculopathy, but can be confused with other conditions.
- Identifying HCQ-related retinal toxicity is complicated due to similarities with other drug-related toxicities, genetic retinal disorders, and systemic diseases.
- The review highlights essential clinical and diagnostic differences to aid ophthalmologists and primary care providers in accurately diagnosing HCQ retinopathy.
Artificial intelligence for detection of retinal toxicity in chloroquine and hydroxychloroquine therapy using multifocal electroretinogram waveforms.
Sci Rep
October 2024
Department of Ophthalmology, University Hospital Erlangen, Schwabachanlage 6, 91054, Erlangen, Germany.
Article Synopsis
- * This study investigates the effectiveness of AI algorithms in detecting retinal damage in patients using these medications, comparing traditional analysis methods with advanced AI approaches.
- * Results indicate that AI models using complete mfERG data are better at identifying disease-related changes than linear models, though challenges like an unbalanced dataset could affect their application.
Association between hydroxychloroquine intake and damage to the outer nuclear layer in eyes without manifest retinal toxicity.
BMC Ophthalmol
September 2024
Eye and Ear Hospital International, Naccache, Lebanon.
Background: Hydroxychloroquine (HCQ) is widely used to treat various autoimmune diseases but carries a risk of retinal toxicity, particularly with prolonged use. Despite advancements, uncertainty persists regarding optimal screening methods. Recent advances in OCT have enabled early detection of retinal damage, with studies suggesting that thinning of specific retinal layers may be an early indicator of toxicity.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!